AstraZeneca signs deal with Canada for 100,000 doses of COVID drug
(Reuters) – AstraZeneca plc signed an agreement with Canada for 100,000 doses of its antibody therapy for prevention of COVID-19 in some high-risk patients, the country’s government said on Wednesday. AstraZeneca’s Evusheld is under review by Health Canada for use as a preventive treatment against the disease in those who are immunocompromised. “While vaccines provide …
AstraZeneca signs deal with Canada for 100,000 doses of COVID drug Read More »